Global Bioactive Peptides Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID : Maia-19449889

No. of pages : 112

Publishing Date : 04-Nov-2021

Bioactive peptides are a form of prepropeptides, which are synthesized in the cell and modified to active proteins. Bioactive Peptides act as signaling molecules in pathogenesis and physiological functions. They are inactive forms and released during food processing or gastrointestinal digestion. Bioactive peptides act as a regulatory compound like hormones after they liberated. The source of bioactive peptides is milk, plant, and meat. Bioactive peptides produced by enzyme proteolysis derived from microorganisms, hydrolysis by digestive enzymes and milk fermentation with proteolytic starter clusters. The most common of production bioactive peptides are enzymatic hydrolysis. Many bioactive active peptides produced using Pepsin or trypsin (produces calcium binding phosphopeptides and Angiotensin-converting enzyme inhibitory peptides). Apart from the natural way of bioactive peptides production, recombinant DNA techniques also used. Bioactive peptides also generated through non-starter and starter bacteria. The also play an important role in the regulation of digestive system and modulation of nutrient absorption. Upon administration, they affect major body systems like digestive, immune, cardiovascular, and nervous system.
The Bioactive Peptides market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Bioactive Peptides market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Bioactive Peptides Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Bioactive Peptides market are:
Naturade
New England Peptide
VentureRadar
WN Pharmaceuticals
Seagarden
Phermpep
Ingredia SA
Arlak Biotech

Most important types of Bioactive Peptides products covered in this report are:
Anti-Hypertensives
Cardiovascular System
Nervous System
Gastrointestinal System
Immune System

Most widely used downstream fields of Bioactive Peptides market covered in this report are:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Drug Store
Mail-Order Pharmacy

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:


Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects...
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects including drivers, restraints...
market Reports market Reports